Text Registration
Copyright Title
Prostate Cancer: Emerging Cancer Therapeutics Volume 2, Issue 3
Status
Published
on 7 Feb 2012
Year of Creation
2011
Copyright Claimant
Demos Medical Publishing, LLC
Registration Number
TX0007487279
on 7 Feb 2012Copyright Summary
The U.S. Copyright record (Registration Number: TX0007487279) dated 7 Feb 2012, pertains to an electronic file (eService) titled "Prostate Cancer: Emerging Cancer Therapeutics Volume 2, Issue 3" created in 2011. The copyright holder is Demos Medical Publishing, LLC, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Demos Medical Publishing, LLC.
Application Details
Registration Number
TX0007487279
Registration Date
2/7/2012
Year of Creation
2011
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Book, 618p
First Publication Nation
United States
ISBN
9781936287468
Notes
Rights Note: Paul Choi, Demos Medical Publishing, 11 W. 42nd Street, 15th Floor, New York, NY, 10036, (212) 683-0072, pchoi@demosmedpub.com
Statements
Application Title Statement: Prostate Cancer: Emerging Cancer Therapeutics Volume 2, Issue 3
Author Statement: James L. Gulley, MD Domicile: United States Citizenship: United States Authorship: editing Jame Abraham, MD Domicile: United States Citizenship: United States Authorship: editing
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.